From Multiomics to Mechanisms – Microbiome-Gut-Host Interactions as a Pathogenetic Driver of Parkinson's Disease Subtypes
Bidragets beskrivning
Parkinson's disease (PD) affects over 5 million people worldwide and 15.000 in Finland. The microbiota-gut-brain axis (MGBA) affects PD symptoms and pathology. Different subtypes of PD may exist with the location of first pathological changes being either in the brain (brain first) or the autonomic nervous system, specifically the gut (body first). Treatments that do not account for such differences will likely fail. We will identify subtypes of PD already in the prodromal phase (before motor symptoms appear) by analyzing genes, gut bacteria, metabolism, and inflammation to profile the MGBA in a large longitudinal cohort of elderly individuals and PD patients. We will compare MGBA pathway alterations (=biomarkers) across different subtypes and disease stages. We will confirm MGBA effects by assessing how fecal microbiota transplantation to rodent models worsens or alleviates PD pathology. This will eventually lead to new personalized treatments for PD.
Visa merStartår
2021
Slutår
2025
Beviljade finansiering
Övriga uppgifter
Finansieringsbeslutets nummer
342758
Vetenskapsområden
Biomedicinska vetenskaper
Forskningsområden
Systeemibiologia, bioinformatiikka
Temaområden
Nuori tutkijasukupolvi 2020
Identifierade teman
brain, neuroscience